Friday, February 10, 2012
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?25 May 2011
White Papers
Focus Area: Manufacturing
1 of 3
Previous |
Next
Manufacturing
New frontiers in drug development
Scott Gottlieb, Deputy Commissioner for Medical and Scientific Affairs at the FDA, gazes into the (very near) future.
No Comments
“Success is about understanding the nuances of our industry and being customer-centric”
John Potthoff, PhD, is President of Clinical Development, North America, at INC Research.
No Comments
Particle Detection in Drug Products
Foreign particles in drug products represent a quality problem for all pharmaceutical manufacturers. They are of a particular concern in the production of pulmonary-inhalable drugs, where the critical size range extends down to 2 microns. By Aspex
No Comments
Time to Produce
How can the industry make use of new manufacturing principles to help squeeze more value out of pharma manufacturing operations? NGP investigates…
No Comments
1 of 3
Previous |
Next
Source: www.ngpharma.com© 2012 GDS Publishing Ltd. All rights reserved.